They reported that AMG510 induced long-term cures in immunocompetent mice with KRASG12C-mutant CT-26 (colorectal) xenograft mice models, and induced tumor regression but not cures in the same mice tumor models lacking T cells (immunocompromised). Here, DDX53 is linked to neoplasm.